Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > January 2012

« Previous month Next month »

News from Sirona, Hospira, and Biogen Idec – People on the move

31-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Sirona, Hospira, and Biogen Idec.

DSM to sell APIs made by Indoco Remedies

31-Jan-2012 - DSM Pharmaceutical Products (DPP) will sell APIs made by Indian manufacturer Indoco Remedies in a new agreement that fits with its global expansion plan.

Dishman considers future of Chinese API plant

31-Jan-2012 - Ingredient maker Dishman Pharmaceuticals has confirmed that it may offload its Chinese API (active pharmaceutical ingredients) factory.

News in brief

Cephalon begins recall after glass flakes found in vial

31-Jan-2012 - Cephalon is recalling a single lot of leukaemia treatment Treanda after glass fragments were found in a vial.

Novartis hit with another 483 after FDA finds repeat failings

31-Jan-2012 - The FDA has hit Novartis with another 483 after finding seven repeat observations and a backlog of 1,360 overdue consumer complaints.

update 2

BASF hikes EOA prices days after asking EU to review US import levies

30-Jan-2012 - BASF has hiked its prices for ethanolamines just days after asking the European Commission to review measures designed to stop US exporters selling the compound  to manufacturers in Europe at...

Patheon boosts solubility enhancing tech offering, says expect more to come

30-Jan-2012 - Patheon will focus its upcoming growth efforts on solubility enhancing tech after receiving an influx of requests from clients.

FDA updates Q&A to cut topical antiseptic contamination

30-Jan-2012 - The FDA has updated its question and answer document to help manufacturers of topical antiseptics prevent contamination.

Zogenix joins with Battelle to out-licence drug delivery tech

30-Jan-2012 - Zogenix is collaborating with Battelle to out-license its needle-free drug delivery technology, DosePro.

Danone and Mead Johnson to make united Pfizer nutrition bid?

27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.

Manufacturing issues round-up

26-Jan-2012 - in-PharmaTechnologist presents a round-up of issues within the pharmaceutical manufacturing industry, including Novartis’ plans to restart Nebraska ops and problems for Roche at it’s South Carolina facility.

US hits Ranbaxy with injunction to boost manufacturing quality

26-Jan-2012 - The US has filed a “groundbreaking” injunction against Ranbaxy to force the generic giant to make “fundamental changes” at its plants.

Simplifying taxes would encourage Pharma manufacturing in France, says govt advisory board

26-Jan-2012 - Simplification of French tax laws would incentivise Pharmas to manufacture drugs in the country according to a government advisory body.

EU could make API suppliers verify starting material sources

26-Jan-2012 - Europe is considering forcing API manufacturers to verify the source of starting materials as part of GMP revisions.


Manufacturing round-up: new facilities in India

25-Jan-2012 - in-PharmaTechnologist presents its round-up of the latest manufacturing headlines including new facilities for Aptar and Granules, and some good news for Swiss Novartis workers.

Albermarle cites favourable pricing and pharma sales as factor in Q4 rev growth

25-Jan-2012 - Ibuprofen API maker Albemarle says favourable volumes and pricing helped drive gains made by fine chemicals unit in Q4.

News in brief

Vivalis grows sales as demand for vaccine cell line increases

25-Jan-2012 - Vivalis nearly doubled revenues from its vaccine production platform in 2011 and has inked a third mAb discovery programme with Sanofi.

Ashland investing in capacity, raising prices in ISP integration

25-Jan-2012 - Ashland is investing in production assets and raising prices as it looks to get the most from its $3.2bn acquisition.


News from Prosonix, GENO, and BioCryst – People on the move

24-Jan-2012 - in-PharmaTechnololist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Prosonix, GENO, and BioCryst.

Granules says Big Pharma demand drove gains in Q3

24-Jan-2012 - Granules India says Big Pharma demand for highly efficient manufacturing in era of patent loss helped it gain market share in Q3 fiscal 2012.

FDA & EMA plant approvals to cut bottlenecks at Genzyme

24-Jan-2012 - The FDA has followed the EMA in approving the Framingham, MA plant that Genzyme hopes will cut production bottlenecks.

News in brief

PolyPid to take delivery tech into trials with new funds

24-Jan-2012 - PolyPid plans to begin clinical development of its novel lipid-polymer fusion-based drug delivery technology with new through a new financing round.

SSB teams with Refine Technology to improve connectivity in biomanufacturing

24-Jan-2012 - Sartorius Stedim Biotech (SSB) says its partnership with Refine Technology will help meet demand for greater connectivity between retention devices and bioreactors and save Pharmas time and money

Pharmacy aseptic failings likely cause of vision loss; researchers

23-Jan-2012 - Poor aseptic technique at compounding pharmacies is the most likely cause of Avastin-related vision loss, researchers claim.

Polytherics buys Warwick Effect Polymers for biodrug modification tech

23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...